Novel benzimidazole phosphonates as potential inhibitors of protein prenylation

Bioorg Med Chem Lett. 2019 Dec 15;29(24):126757. doi: 10.1016/j.bmcl.2019.126757. Epub 2019 Oct 31.

Abstract

Benzimidazole carboxyphosphonates and bisphosphonates have been prepared and evaluated for their activity as inhibitors of protein prenylation or isoprenoid biosynthesis. The nature of the phosphonate head group was found to dictate enzyme specificity. The lead carboxyphosphonate inhibits geranylgeranyl transferase II while its corresponding bisphosphonate analogue potently inhibits farnesyl diphosphate synthase. The most active inhibitors effectively disrupted protein prenylation in human multiple myeloma cells.

Keywords: Benzimidazole; Bisphosphonate; Carboxyphosphonate; Farnesyl diphosphate synthase; Geranylgeranyl transferase II; Inhibition; Isoprenoid biosynthesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / antagonists & inhibitors*
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use*
  • Humans
  • Organophosphonates / antagonists & inhibitors*
  • Organophosphonates / pharmacology
  • Organophosphonates / therapeutic use*
  • Protein Prenylation / drug effects*

Substances

  • Benzimidazoles
  • Organophosphonates